SpyGlass Pharma, Inc. (SGP)
SpyGlass Pharma, Inc. (SGP)
| Balance Sheets | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 238,902 | 96,358 | ||
| Short-term investments | 12,100 | 11,078 | ||
| Other receivables | 653 | 431 | ||
| Prepaid expenses and other current assets | 1,707 | 901 | ||
| Total current assets | 253,362 | 108,768 | ||
| Other non-current assets | 789 | 492 | ||
| Property and equipment, net | 2,745 | 2,339 | ||
| Deferred offering costs | 0 | 2,715 | ||
| Right-of-use asset | 1,490 | 1,552 | ||
| Total assets | 258,386 | 115,866 | ||
| Accounts payable | 3,514 | 2,696 | ||
| Payroll-related accruals | 882 | 2,182 | ||
| Other current liabilities | 2,271 | 3,706 | ||
| Lease liability, current | - | 0 | ||
| Redeemable convertible preferred stock tranche liability | - | 0 | ||
| Total current liabilities | 6,667 | 8,584 | ||
| Lease liability, non-current | 1,607 | 1,582 | ||
| Total liabilities | 8,274 | 10,166 | ||
| Redeemable convertible preferred stock, .00001 par value zero shares authorized, issued and outstanding as of march 31, 2026 116,618,581 shares authorized, 20,341,968 shares issued and outstanding as of december 31, 2025 (aggregate liquidation preference of zero and 200,878 as of march 31, 2026 and december 31, 2025, respectively) | 0 | 204,537 | ||
| Preferred stock, .00001 par value 200,000,000 shares authorized, zero shares issued and outstanding as of march 31, 2026 zero shares authorized, issued, and outstanding as of december 31, 2025 | 0 | - | ||
| Common stock, .00001 par value 1,000,000,000 shares authorized 33,432,555 shares issued and outstanding as of march31, 2026 154,383,336 shares authorized 2,203,620 shares issued and outstanding as of december31, 2025 | 0 | 0 | ||
| Common stock additional paid-in capital | 368,660 | 5,893 | ||
| Accumulated deficit | -118,548 | -104,730 | ||
| Total stockholders' equity (deficit) | 250,112 | -98,837 | ||
| Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | 258,386 | 115,866 | ||